Showing results (71-80 of 440) with videos related to
Sort By:
Pageof 44
Pharmacology & Therapeutics|July 21, 2009
Genetic modulation of the pharmacological treatment of painJörn Lötsch, Gerd Geisslinger, Irmgard TegederProstaglandins & Other Lipid Mediators|November 7, 2006
LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samplesHelmut Schmidt, Ronald Schmidt, Gerd GeisslingerNeuropharmacology|July 1, 2026
TRPC5 as a Modulator of TRPV1 Signalling in Pathological Pain StatesChristian Müller, Gerd Geisslinger, Marco SisignanoJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 23, 2003
Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisationLutz Bräutigam, Jens U Nefflen, Gerd GeisslingerDrug Safety|February 6, 2004
Benefit-risk assessment of rofecoxib in the treatment of osteoarthritisHelmut Schmidt, Barry G Woodcock, Gerd GeisslingerJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 20, 2006
High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia (PCEA)Ronald Schmidt, Dorothee H Bremerich, Gerd GeisslingerTrends in Pharmacological Sciences|May 13, 2019
Novel Approaches to Persistent Pain TherapyMarco Sisignano, Michael J Parnham, Gerd GeisslingerTrends in Pharmacological Sciences|December 27, 2015
Drug Repurposing for the Development of Novel AnalgesicsMarco Sisignano, Michael J Parnham, Gerd GeisslingerProgress in Lipid Research|June 28, 2020
Influence of glycosphingolipids on cancer cell energy metabolismNina Schömel, Gerd Geisslinger, Marthe-Susanna WegnerThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 8, 2008
Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent inflammatory painAchim Schmidtko, Wei Gao, Matthias Sausbier, et al.Pageof 44